New diabetes pill enters early human testing

NCT ID NCT07234864

Ongoing Disease control Sponsor: Eilean Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing a new oral drug called ZE63-0302 in 60 adults with type 2 diabetes. The main goal is to check the drug's safety and how the body handles it, not yet whether it works. Participants will take either the drug or a placebo capsule twice a day for a short time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ZE63-0302 (oral capsules)
What this could lead to: If this early trial shows the drug is safe and well-tolerated, it could pave the way for a new oral medication to help control blood sugar in type 2 diabetes.
What could go wrong: This is a very early Phase 1 study with only 60 people, focused on safety and drug levels, not on whether it actually improves diabetes. Many drugs fail at this stage, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Emeritus Research Camberwell

Melbourne, Victoria, 3124, Australia
Emeritus Research Sydney

Botany, New South Wales, 2019, Australia
Momentum Clinical Research Sunshine

Melbourne, Victoria, 3021, Australia
Momentum Clinical Research Taringa

Brisbane, Queensland, 4068, Australia
Momentum Dunedin

Dunedin, Otago, 9016, New Zealand
Momentum Wellington

Wellington, Wellington Region, 6011, New Zealand
PCRN Christchurch

Christchurch, Canterbury, 8013, New Zealand
PCRN Rotorua

Rotorua, Bay of Plenty, 3010, New Zealand
PCRN Waikato

Hamilton, Waikato Region, 3200, New Zealand
The Republican Specialized Scientific and Prectical Medical Center of Endocrinology named after Academician Yo. Kh. Turakulov

Tashkent, Tashkent, 100125, Uzbekistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.